ALID.OTC.PinkAllied CORP

10-Q: Allied Corp. Reports Q1 2024 Results with Revenue Decline and Continued Losses

Sentiment:

Quarterly Report


Allied Corp. reports a net loss of $836,673 for the quarter ended November 30, 2023, with a significant decrease in revenue compared to the same period last year.

Delay expectedThe company has defaulted on all of its convertible notes and is in the process of amending the maturity dates and conversion prices.
Capital raiseThe company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing.The company will require additional funding to finance the growth of its current and expected future operations as well as to achieve its strategic objectives.
Worse than expectedThe company's revenue decreased significantly year-over-year.The company's net loss was substantial and worse than the previous year.The company's cash balance decreased significantly from the previous quarter.The company has a substantial working capital deficit.

Summary

  • Allied Corp. reported a net loss of $836,673 for the three months ended November 30, 2023, compared to a net loss of $1,309,541 for the same period in 2022.
  • The company's revenue decreased to $19,039 in Q1 2024 from $69,625 in Q1 2023.
  • Gross margin also decreased to $17,036 from $43,667 year-over-year.
  • Operating expenses were $760,842 for the quarter, down from $1,242,966 in the prior year.
  • The company has a working capital deficit of $8,699,414 as of November 30, 2023.
  • Allied Corp. is relying on equity and debt financing to fund operations and future development.
  • The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with significant revenue decline, substantial losses, a large working capital deficit, and defaults on debt. While there are some positive aspects like reduced operating expenses, the overall sentiment is negative due to the company's financial instability and reliance on future financing.

Positives

  • Operating expenses decreased significantly year-over-year, indicating some cost control measures.
  • The net loss decreased compared to the same period last year, although still substantial.

Negatives

  • The company experienced a significant decrease in revenue year-over-year.
  • The company has a substantial working capital deficit, raising concerns about its ability to meet short-term obligations.
  • The company's cash balance has decreased significantly from the previous quarter.
  • The company has a large amount of debt in the form of secured convertible notes payable.
  • The company has defaulted on all of its convertible notes and is in the process of amending the maturity dates and conversion prices.

Risks

  • The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
  • The company has a significant working capital deficit and may struggle to meet its financial obligations.
  • The company is reliant on equity and debt financing, which may not be available on favorable terms.
  • The company has defaulted on all of its convertible notes, which could lead to further financial strain.
  • The company is involved in legal proceedings regarding a land lease and ownership of buildings in Nevada, which could result in further losses.

Future Outlook

The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing to develop a profitable business. Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing with some additional funding from other traditional financing sources, including related party loans until such time that funds provided by future planned operations are sufficient to fund working capital requirements.

Management Comments

  • Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing with some additional funding from other traditional financing sources, including related party loans until such time that funds provided by future planned operations are sufficient to fund working capital requirements.
  • Our management team believes that having control over our supply chain should enable us to provide a consistent, rolling-harvest supply to the global cannabis community.
  • Allied Corps commitment to building and maintaining strong relationships with its partners and customers around the world has been a driving force behind its recent successes.

Industry Context

The company operates in the medical cannabis industry, which is subject to evolving regulations and market conditions. The company's focus on low-cost production in Colombia and international distribution is a strategy to gain a competitive advantage. However, the company faces risks related to the legality of cannabis in the United States and the evolving regulatory landscape in Colombia.

Comparison to Industry Standards

  • The company's revenue of $19,039 is significantly lower than many established cannabis companies, indicating a very early stage of commercialization.
  • The company's gross margin of $17,036 is also low, suggesting challenges in achieving profitability.
  • The company's operating expenses of $760,842 are high relative to its revenue, indicating a need for cost control.
  • The company's working capital deficit of $8,699,414 is a significant concern, as many cannabis companies struggle with cash flow and require ongoing capital raises.
  • The company's reliance on convertible notes and equity financing is common in the cannabis industry, but the high level of debt and defaults on notes are concerning.
  • Compared to companies like Canopy Growth or Aurora Cannabis, which have established brands and distribution networks, Allied Corp. is in a much earlier stage of development and faces significant challenges in achieving profitability and sustainability.

Legal Proceedings

  • The company is involved in legal proceedings regarding a land lease and ownership of buildings in Nevada.
  • The company filed a complaint in the Eighth Judicial District Court in Clark County, Nevada seeking injunctive relief to terminate a trustees sale or alternatively money damages.
  • The company filed suit, seeking a declaration of the Companys ownership of the buildings as the buildings were personal property and not a part of the real property.

Related Party Transactions

  • The company has significant amounts due to related parties, including directors and officers.
  • The company shares certain administrative resources with companies related by common management and directors.

Stakeholder Impact

  • Shareholders are at risk due to the company's financial instability and reliance on future financing.
  • Employees may be affected by potential cost-cutting measures or operational changes.
  • Creditors are at risk due to the company's defaults on convertible notes.
  • Customers may be affected by potential disruptions in the company's operations.

Next Steps

  • The company needs to secure additional financing to continue operations.
  • The company needs to address the defaults on its convertible notes.
  • The company needs to resolve the legal proceedings regarding the land lease and building ownership in Nevada.
  • The company needs to improve its revenue generation and cost control measures.

Key Dates

DateDescription
2013-02-03Allied Corp. was incorporated in the State of Nevada.
2018-09-13Date of incorporation of AM Biosciences, treated as the acquirer in a reverse takeover.
2019-07-01The Company changed its name to Allied Corp.
2019-08-29Allied Corp. entered into a Share Purchase Agreement to acquire Baleno Ltd.
2019-09-10The Company was acquired in a reverse takeover transaction.
2020-02-17The Company closed and completed the acquisition of Medicolombia (now Allied Colombia).
2020-02-18The Company acquired all the issued and outstanding share capital of Allied Colombia S.A.S.
2020-05-29The Company made a payment at commencement date for a financing agreement.
2020-06-20The Company began making monthly interest payments for a financing agreement.
2020-07-01The Company entered into amendments to convertible notes.
2020-07-20Maturity date of convertible notes issued on January 23, 2020.
2020-09-29The Company issued a convertible note.
2020-10-26The Company issued a convertible note.
2020-11-01The Company entered into amendments to convertible notes.
2020-11-11The Company issued a convertible note.
2020-12-02The Company issued a convertible note.
2021-01-07The Company issued a convertible note.
2021-03-26The Company issued a convertible note.
2021-03-30Allied US Products LLC entered into a contingent asset purchase agreement.
2021-03-31The Company entered into amendments to convertible notes.
2021-04-29The Company issued a convertible note.
2021-06-01The Company entered into amendments to convertible notes.
2021-07-25The Company issued a convertible note.
2021-08-10The Company entered into a lease for additional land in Colombia.
2021-10-01The Company entered into amendments to convertible notes.
2021-10-25The Company issued a convertible note.
2021-11-01The Company entered into amendments to convertible notes.
2021-12-17The Company entered into a financing agreement to finance an equipment purchase.
2021-12-23The Company issued a convertible note.
2021-12-27The Company entered into an amendment agreement for a loan.
2022-01-11The Company issued a convertible note.
2022-01-20The Company began making monthly payments for a loan.
2022-01-31The Company issued a convertible note.
2022-03-29The Company issued a convertible note.
2022-03-31The Company entered into amendments to convertible notes.
2022-06-16The Company issued a convertible note.
2022-09-21The Company issued shares of common stock.
2022-09-30The Company defaulted on several convertible notes.
2022-10-07The Company issued shares of common stock.
2022-11-28The Company issued a convertible note.
2022-12-01The Company issued a convertible note.
2022-12-07The Company issued a convertible note.
2022-12-13A status conference was held for legal proceedings in Nevada.
2023-02-28The Company issued a convertible note.
2023-05-17The Company issued a convertible note.
2023-08-31The Company terminated a lease.
2023-09-05The Company issued shares of common stock.
2023-09-17The Company defaulted on a convertible note.
2023-10-20The Company issued shares of common stock.
2023-11-30End of the reporting period for this quarterly report.
2023-12-01The Company issued shares of common stock.
2023-12-04The Company issued a secured convertible note.
2023-12-20The Company modified the exercise prices and expiry dates for previously granted and unexercised options.
2024-01-16Date of the filing of this quarterly report.

Keywords

cannabis, medical cannabis, financial results, quarterly report, convertible notes, working capital, net loss, revenue, operating expenses, debt, Colombia, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.